Is Pazopanib a chemotherapy drug?

Pazopanib(Pazopanib) is a targeted therapy drug rather than a traditional chemotherapy drug. It belongs to a class of drugs called tyrosine kinase inhibitors, also known as cancer growth inhibitors, and is used primarily to treat renal cell carcinoma and soft tissue sarcomas. Compared with traditional chemotherapy drugs, targeted therapy drugs are more specific and can act on cancer cells more precisely, thereby reducing damage to healthy cells.

Pazopanib is a targeted drug that works by inhibiting signaling pathways that regulate angiogenesis and tumor cell growth. Kinases are important proteins in the body. They control how cells grow and divide. Pazopanib blocks proteins (kinases) that signal cancer cells to grow. Blocking the signal causes cancer cells to die. Pazopanib also prevents cancer cells from developing new blood vessels. This reduces their supply of oxygen and nutrients, so tumors shrink or stop growing. This is called anti-angiogenic therapy.

PazopanibThe original drug has been launched in China and has entered the scope of Class B medical insurance, but reimbursement is limited to patients who meet the indications. The price of each box may be around 3,000 yuan. The price of pazopanib original drug specifications200mg*30 tablets marketed overseas may be around 1,000 RMB per box (the price may fluctuate due to exchange rates). There are also pazopanib generic drugs produced in other countries. The price of 200mg*30 tablets produced by Bangladesh pharmaceutical factory may be around 500 yuan per box (the price may fluctuate due to the exchange rate), which is cheaper. The pharmaceutical ingredients of generic drugs are basically the same as those of domestic and foreign original drugs.